The information in this preliminary pricing supplement is not
complete and may be changed. This preliminary pricing supplement is
not an offer to sell nor does it seek an offer to buy these
securities in any jurisdiction where the offer or sale is not
permitted.
Subject to completion dated June 1,
2023
June , 2023 |
Registration Statement Nos. 333-270004 and 333-270004-01; Rule
424(b)(2)
|

JPMorgan
Chase Financial Company LLC
Structured Investments
Uncapped Accelerated Barrier Notes Linked to the Lesser Performing
of the iShares® MSCI EAFE ETF and the EURO STOXX
50® Index due June 30, 2028
Fully and
Unconditionally Guaranteed by JPMorgan
Chase & Co.
|
● |
The notes are designed for investors who seek an uncapped
return of at least 1.95 times any appreciation of the lesser
performing of the iShares® MSCI EAFE ETF and the EURO
STOXX 50® Index, which we refer to as the Underlyings,
at maturity. |
|
● |
Investors should be willing to forgo interest and dividend
payments and be willing to lose some or all of their principal
amount at maturity. |
|
● |
The notes are unsecured and unsubordinated obligations of
JPMorgan Chase Financial Company LLC, which we refer to as JPMorgan
Financial, the payment on which is fully and unconditionally
guaranteed by JPMorgan Chase & Co. Any payment on
the notes is subject to the credit risk of JPMorgan Financial, as
issuer of the notes, and the credit risk of JPMorgan
Chase & Co., as guarantor of the notes. |
|
● |
Payments on the notes are not linked to a basket composed of
the Underlyings. Payments on the notes are linked to the
performance of each of the Underlyings individually, as described
below. |
|
● |
Minimum denominations of $1,000 and integral multiples
thereof |
|
● |
The notes are expected to price on or about June
27, 2023 and are expected to settle on or about June 30,
2023. |
Investing in the notes involves a number of risks. See “Risk
Factors” beginning on page S-2 of the accompanying prospectus
supplement, “Risk Factors” beginning on page PS-11 of the
accompanying product supplement and “Selected Risk Considerations”
beginning on page PS-3 of this pricing supplement.
Neither the Securities and Exchange Commission (the “SEC”) nor any
state securities commission has approved or disapproved of the
notes or passed upon the accuracy or the adequacy of this pricing
supplement or the accompanying product supplement, underlying
supplement, prospectus supplement and prospectus. Any
representation to the contrary is a criminal offense.
|
Price to Public (1) |
Fees and Commissions (2) |
Proceeds to Issuer |
Per note |
$1,000 |
$ |
$ |
Total |
$ |
$ |
$ |
(1) See “Supplemental Use of Proceeds” in this pricing supplement
for information about the components of the price to public of the
notes.
(2) J.P. Morgan Securities LLC, which we refer to as JPMS, acting
as agent for JPMorgan Financial, will pay all of the selling
commissions it receives from us to other affiliated or unaffiliated
dealers. In no event will these selling commissions exceed $41.25
per $1,000 principal amount note. See “Plan of Distribution
(Conflicts of Interest)” in the accompanying product
supplement.
|
If the notes priced today, the estimated value of the notes
would be approximately $922.80 per $1,000 principal amount note.
The estimated value of the notes, when the terms of the notes are
set, will be provided in the pricing supplement and will not be
less than $900.00 per $1,000 principal amount note. See “The
Estimated Value of the Notes” in this pricing supplement for
additional information.
The notes are not bank deposits, are not insured by the Federal
Deposit Insurance Corporation or any other governmental agency and
are not obligations of, or guaranteed by, a bank.
Pricing supplement to product supplement no. 4-I dated April 13,
2023, underlying supplement no. 1-I dated April 13, 2023 and the
prospectus and prospectus supplement, each dated April 13, 2023
Key Terms
Issuer:
JPMorgan
Chase Financial Company LLC, an indirect, wholly owned finance
subsidiary of JPMorgan Chase & Co.
Guarantor:
JPMorgan
Chase & Co.
Underlyings:
The EURO STOXX 50®
Index (Bloomberg ticker: SX5E) (the “Index”) and the
iShares®
MSCI EAFE ETF (Bloomberg ticker: EFA) (the “Fund”) (each of the
Index and the Fund, an “Underlying” and collectively, the
“Underlyings”)
Upside Leverage
Factor: At least
1.95 (to be provided in the pricing supplement)
Barrier
Amount: With respect to each Underlying, 70.00% of its
Initial Value
Pricing Date:
On or about June 27, 2023
Original Issue Date (Settlement Date):
On or about June 30, 2023
Observation Date*:
June 27, 2028
Maturity Date*:
June 30, 2028
* Subject to postponement in the event of a market disruption event
and as described under “General Terms of Notes — Postponement of a
Determination Date — Notes Linked to Multiple Underlyings” and
“General Terms of Notes — Postponement of a Payment Date” in the
accompanying product supplement or early acceleration in the
event of a change-in-law event as described under “General Terms of
Notes — Consequences of a Change-in-Law Event” in the accompanying
product supplement and “Selected Risk Considerations — We May
Accelerate Your Notes If a Change-in-Law Event Occurs” in this
pricing supplement
|
|
Payment at Maturity:
If the Final
Value of each Underlying is greater than its Initial Value, your
payment at maturity per $1,000 principal amount note will be
calculated as follows:
$1,000 +
($1,000 × Lesser Performing Underlying Return × Upside Leverage
Factor)
If the Final Value of either Underlying is equal to or less than
its Initial Value but the Final Value of each Underlying is greater
than or equal to its Barrier Amount, you will receive the principal
amount of your notes at maturity.
If the Final Value of either Underlying is less than its Barrier
Amount, your payment at maturity
per $1,000 principal amount note will be calculated as
follows:
$1,000 + ($1,000
× Lesser Performing
Underlying Return)
If the Final Value
of either Underlying is less than its Barrier Amount, you
will lose more than 30.00% of your principal amount at maturity and
could lose all of your principal amount at maturity.
Lesser
Performing Underlying: The
Underlying with the Lesser Performing Underlying Return
Lesser
Performing Underlying Return: The lower
of the Underlying Returns of the Underlyings
Underlying
Return: With respect to each Underlying,
(Final
Value – Initial Value)
Initial Value
Initial
Value: With respect to each Underlying, the
closing value of that Underlying on the Pricing Date
Final
Value: With respect to each Underlying, the
closing value of that Underlying on the Observation Date
Share
Adjustment Factor: The Share Adjustment Factor is
referenced in determining the closing value of the Fund and is set
equal to 1.0 on the Pricing Date. The Share Adjustment Factor is
subject to adjustment upon the occurrence of certain events
affecting the Fund. See “The Underlyings — Funds — Anti-Dilution
Adjustments” in the accompanying product supplement for further
information.
|
PS-1
| Structured Investments
Uncapped Accelerated Barrier Notes Linked to the Lesser Performing
of the iShares® MSCI EAFE ETF and the EURO STOXX
50® Index
|
 |
Hypothetical Payout Profile
The following table and graph illustrate the hypothetical total
return and payment at maturity on the notes linked to two
hypothetical Underlyings. The “total return” as used in this
pricing supplement is the number, expressed as a percentage, that
results from comparing the payment at maturity per $1,000 principal
amount note to $1,000. The hypothetical total returns and payments
set forth below assume the following:
|
● |
an
Initial Value for the Lesser Performing Underlying
of
100.00; |
|
● |
an
Upside Leverage Factor of 1.95; and |
|
● |
a Barrier Amount for the Lesser Performing Underlying of 70.00
(equal to 70.00% of its hypothetical Initial Value). |
The hypothetical Initial Value of the Lesser Performing Underlying
of 100.00 has been chosen for illustrative purposes only and may
not represent a likely actual Initial Value of either Underlying.
The actual Initial Value of each Underlying will be the closing
value of that Underlying on the Pricing Date and will be provided
in the pricing supplement. For historical data regarding the actual
closing values of each Underlying, please see the historical
information set forth under “The Underlyings” in this pricing
supplement.
Each hypothetical total return or hypothetical payment at maturity
set forth below is for illustrative purposes only and may not be
the actual total return or payment at maturity applicable to a
purchaser of the notes. The numbers appearing in the following
table and graph have been rounded for ease of analysis.
Final Value of the
Lesser Performing
Underlying |
Lesser Performing
Underlying Return |
Total Return on the
Notes |
Payment at Maturity |
180.00 |
80.00% |
156.00% |
$2,560.00 |
170.00 |
70.00% |
136.50% |
$2,365.00 |
160.00 |
60.00% |
117.00% |
$2,170.00 |
150.00 |
50.00% |
97.50% |
$1,975.00 |
140.00 |
40.00% |
78.00% |
$1,780.00 |
130.00 |
30.00% |
58.50% |
$1,585.00 |
120.00 |
20.00% |
39.00% |
$1,390.00 |
110.00 |
10.00% |
19.50% |
$1,195.00 |
105.00 |
5.00% |
9.75% |
$1,097.50 |
101.00 |
1.00% |
1.95% |
$1,019.50 |
100.00 |
0.00% |
0.00% |
$1,000.00 |
95.00 |
-5.00% |
0.00% |
$1,000.00 |
90.00 |
-10.00% |
0.00% |
$1,000.00 |
80.00 |
-20.00% |
0.00% |
$1,000.00 |
70.00 |
-30.00% |
0.00% |
$1,000.00 |
69.99 |
-30.01% |
-30.01% |
$699.90 |
60.00 |
-40.00% |
-40.00% |
$600.00 |
50.00 |
-50.00% |
-50.00% |
$500.00 |
40.00 |
-60.00% |
-60.00% |
$400.00 |
30.00 |
-70.00% |
-70.00% |
$300.00 |
20.00 |
-80.00% |
-80.00% |
$200.00 |
10.00 |
-90.00% |
-90.00% |
$100.00 |
0.00 |
-100.00% |
-100.00% |
$0.00 |
PS-2
| Structured Investments
Uncapped Accelerated Barrier Notes Linked to the Lesser Performing
of the iShares® MSCI EAFE ETF and the EURO STOXX
50® Index
|
 |
The following graph demonstrates the hypothetical payments at
maturity on the notes for a sub-set of Lesser Performing Underlying
Returns detailed in the table above (-80% to 80%). There can be no
assurance that the performance of the Lesser Performing Underlying
will result in the return of any of your principal amount.

How the Notes Work
Upside Scenario:
If the Final Value of each Underlying is greater than its Initial
Value, investors will receive at maturity the $1,000 principal
amount plus a return equal to the Lesser Performing
Underlying Return times the Upside Leverage Factor of at
least 1.95.
|
● |
Assuming a hypothetical Upside Leverage Factor of 1.95, if the
closing value of the Lesser Performing Underlying increases 10.00%,
investors will receive at maturity a return of 19.50%, or $1,195.00
per $1,000 principal amount note. |
Par Scenario:
If the Final Value of either Underlying is equal to or is less than
its Initial Value but the Final Value of each Underlying is greater
than or equal to its Barrier Amount of 70.00% of its Initial Value,
investors will receive at maturity the principal amount of their
notes.
Downside Scenario:
If the Final Value of either Underlying is less than its Barrier
Amount of 70.00% of its Initial Value, investors will lose 1% of
the principal amount of their notes for every 1% that the Final
Value of the Lesser Performing Underlying is less than its Initial
Value.
|
● |
For example, if the closing value of the Lesser Performing
Underlying declines 60.00%, investors will lose 60.00% of their
principal amount and receive only $400.00 per $1,000 principal
amount note at maturity. |
The hypothetical returns and hypothetical payments on the notes
shown above apply only if you hold the notes for their entire
term. These hypotheticals do not reflect the fees or expenses
that would be associated with any sale in the secondary market. If
these fees and expenses were included, the hypothetical returns and
hypothetical payments shown above would likely be lower.
Selected Risk Considerations
An investment in the notes involves significant risks. These risks
are explained in more detail in the “Risk Factors” sections of the
accompanying prospectus supplement and product supplement.
|
● |
YOUR INVESTMENT IN THE NOTES MAY RESULT IN A LOSS —
The notes do not guarantee any return of principal. If the Final
Value of either Underlying is less than its Barrier Amount, you
will lose 1% of the principal amount of your notes for every 1%
that the Final Value of the Lesser Performing Underlying is less
than its Initial Value. Accordingly, under these circumstances, you
will lose more than
30.00% of your principal amount at maturity and could lose
all of your principal amount at maturity. |
|
● |
CREDIT RISKS OF JPMORGAN FINANCIAL AND JPMORGAN
CHASE & CO. —
Investors are dependent on our and JPMorgan
Chase & Co.’s ability to pay all amounts due on the
notes. Any actual or potential change in our or JPMorgan
Chase & Co.’s creditworthiness or credit spreads, as
determined by the market for taking that credit risk, is likely to
adversely affect the value of the notes. If we and JPMorgan
Chase & Co. were to default on our payment
obligations, you may not receive any amounts owed to you under the
notes and you could lose your entire investment. |
PS-3
| Structured Investments
Uncapped Accelerated Barrier Notes Linked to the Lesser Performing
of the iShares® MSCI EAFE ETF and the EURO STOXX
50® Index
|
 |
|
● |
AS A FINANCE SUBSIDIARY, JPMORGAN FINANCIAL HAS NO
INDEPENDENT OPERATIONS AND HAS LIMITED ASSETS —
As a finance subsidiary of JPMorgan Chase & Co., we
have no independent operations beyond the issuance and
administration of our securities. Aside from the initial capital
contribution from JPMorgan Chase & Co., substantially
all of our assets relate to obligations of our affiliates to make
payments under loans made by us or other intercompany agreements.
As a result, we are dependent upon payments from our affiliates to
meet our obligations under the notes. If these affiliates do not
make payments to us and we fail to make payments on the notes, you
may have to seek payment under the related guarantee by JPMorgan
Chase & Co., and that guarantee will rank pari
passu with all other unsecured and unsubordinated obligations
of JPMorgan Chase & Co. |
|
● |
THE BENEFIT PROVIDED BY THE BARRIER AMOUNT MAY TERMINATE ON
THE OBSERVATION DATE —
If the Final Value of either Underlying is less than its Barrier
Amount, the benefit provided by the Barrier Amount will terminate
and you will be fully exposed to any depreciation of the Lesser
Performing Underlying. |
|
● |
POTENTIAL CONFLICTS —
We and our affiliates play a variety of roles in connection with
the notes. In performing these duties, our and JPMorgan
Chase & Co.’s economic interests are potentially
adverse to your interests as an investor in the notes. It is
possible that hedging or trading activities of ours or our
affiliates in connection with the notes could result in substantial
returns for us or our affiliates while the value of the notes
declines. Please refer to “Risk Factors — Risks Relating to
Conflicts of Interest” in the accompanying product supplement. |
|
● |
THE NOTES DO NOT PAY INTEREST. |
|
● |
YOU WILL NOT RECEIVE DIVIDENDS ON THE FUND OR THE SECURITIES
INCLUDED IN OR HELD BY EITHER UNDERLYING OR HAVE ANY RIGHTS WITH
RESPECT TO THE FUND OR THOSE SECURITIES. |
|
● |
THE RISK OF THE CLOSING VALUE OF AN UNDERLYING FALLING BELOW
ITS BARRIER AMOUNT IS GREATER IF THE VALUE OF THAT UNDERLYING IS
VOLATILE. |
|
● |
THERE ARE RISKS ASSOCIATED WITH THE FUND —
The Fund is subject to management risk, which is the risk that the
investment strategies of the Fund’s investment adviser, the
implementation of which is subject to a number of constraints, may
not produce the intended results. These constraints could adversely
affect the market price of the shares of the Fund and,
consequently, the value of the notes. |
|
● |
THE PERFORMANCE AND MARKET VALUE OF THE FUND, PARTICULARLY
DURING PERIODS OF MARKET VOLATILITY, MAY NOT CORRELATE WITH THE
PERFORMANCE OF THE FUND’S UNDERLYING INDEX AS WELL AS THE NET ASSET
VALUE PER SHARE —
The Fund does not fully replicate its Underlying Index (as defined
under “The Underlyings” below) and may hold securities different
from those included in its Underlying Index. In addition, the
performance of the Fund will reflect additional transaction costs
and fees that are not included in the calculation of its Underlying
Index. All of these factors may lead to a lack of correlation
between the performance of the Fund and its Underlying Index. In
addition, corporate actions with respect to the equity securities
underlying the Fund (such as mergers and spin-offs) may impact the
variance between the performances of the Fund and its Underlying
Index. Finally, because the shares of the Fund are traded on a
securities exchange and are subject to market supply and investor
demand, the market value of one share of the Fund may differ from
the net asset value per share of the Fund.
During periods of market volatility, securities underlying the Fund
may be unavailable in the secondary market, market participants may
be unable to calculate accurately the net asset value per share of
the Fund and the liquidity of the Fund may be adversely affected.
This kind of market volatility may also disrupt the ability of
market participants to create and redeem shares of the Fund.
Further, market volatility may adversely affect, sometimes
materially, the prices at which market participants are willing to
buy and sell shares of the Fund. As a result, under these
circumstances, the market value of shares of the Fund may vary
substantially from the net asset value per share of the Fund. For
all of the foregoing reasons, the performance of the Fund may not
correlate with the performance of its Underlying Index as well as
the net asset value per share of the Fund, which could materially
and adversely affect the value of the notes in the secondary market
and/or reduce any payment on the notes. |
|
● |
NON-U.S. SECURITIES RISK —
The equity securities included in or held by the Underlyings have
been issued by non-U.S. companies. Investments in securities
linked to the value of such non-U.S. equity securities involve
risks associated with the securities markets in the home countries
of the issuers of those non-U.S. equity securities. Also, there is
generally less publicly available information about companies in
some of these jurisdictions than there is about U.S. companies that
are subject to the reporting requirements of the SEC. |
PS-4
| Structured Investments
Uncapped Accelerated Barrier Notes Linked to the Lesser Performing
of the iShares® MSCI EAFE ETF and the EURO STOXX
50® Index
|
 |
|
● |
THE NOTES ARE SUBJECT TO CURRENCY EXCHANGE RISK WITH RESPECT
TO THE FUND —
Because the prices of the equity securities held by the Fund are
converted into U.S. dollars for purposes of calculating the net
asset value of the Fund, holders of the notes will be exposed to
currency exchange rate risk with respect to each of the currencies
in which the equity securities held by the Fund trade. Your net
exposure will depend on the extent to which those currencies
strengthen or weaken against the U.S. dollar and the relative
weight of equity securities held by the Fund denominated in each of
those currencies. If, taking into account the relevant weighting,
the U.S. dollar strengthens against those currencies, the price of
the Fund will be adversely affected and any payment on the notes
may be reduced. |
|
● |
NO DIRECT EXPOSURE TO FLUCTUATIONS IN FOREIGN EXCHANGE RATES
WITH RESPECT TO THE INDEX —
The value of your notes will not be adjusted for exchange rate
fluctuations between the U.S. dollar and the currencies upon which
the equity securities included in the Index are based, although any
currency fluctuations could affect the performance of the
Index. |
|
● |
YOU ARE EXPOSED TO THE RISK OF DECLINE IN THE VALUE OF EACH
UNDERLYING —
Payments on the notes are not linked to a basket composed of the
Underlyings and are contingent upon the performance of each
individual Underlying. Poor performance by either of the
Underlyings over the term of the notes may negatively affect your
payment at maturity and will not be offset or mitigated by positive
performance by the other Underlying. |
|
● |
YOUR PAYMENT AT MATURITY WILL BE DETERMINED BY THE LESSER
PERFORMING UNDERLYING. |
|
● |
THE ANTI-DILUTION PROTECTION FOR THE FUND IS LIMITED
—
The calculation agent will make adjustments to the Share Adjustment
Factor for the Fund for certain events affecting the shares of the
Fund. However, the calculation agent will not make an adjustment in
response to all events that could affect the shares of the Fund. If
an event occurs that does not require the calculation agent to make
an adjustment, the value of the notes may be materially and
adversely affected. |
|
● |
WE MAY ACCELERATE YOUR NOTES IF A CHANGE-IN-LAW EVENT OCCURS
—
Upon the announcement or occurrence of legal or regulatory changes
that the calculation agent determines are likely to interfere with
your or our ability to transact in or hold the notes or our ability
to hedge or perform our obligations under the notes, we may, in our
sole and absolute discretion, accelerate the payment on your notes
and pay you an amount determined in good faith and in a
commercially reasonable manner by the calculation agent. If the
payment on your notes is accelerated, your investment may result in
a loss and you may not be able to reinvest your money in a
comparable investment. Please see “General Terms of Notes —
Consequences of a Change-in-Law Event” in the accompanying product
supplement for more information. |
|
● |
LACK OF LIQUIDITY —
The notes will not be listed on any securities exchange.
Accordingly, the price at which you may be able to trade your notes
is likely to depend on the price, if any, at which JPMS is willing
to buy the notes. You may not be able to sell your notes. The notes
are not designed to be short-term trading instruments. Accordingly,
you should be able and willing to hold your notes to maturity. |
|
● |
THE FINAL TERMS AND VALUATION OF THE NOTES WILL BE PROVIDED
IN THE PRICING SUPPLEMENT —
You should consider your potential investment in the notes based on
the minimums for the estimated value of the notes and the Upside
Leverage Factor. |
|
● |
THE TAX DISCLOSURE IS SUBJECT TO CONFIRMATION —
The information set forth under “Tax Treatment” in this pricing
supplement remains subject to confirmation by our special tax
counsel following the pricing of the notes. If that information
cannot be confirmed by our tax counsel, you may be asked to accept
revisions to that information in connection with your purchase.
Under these circumstances, if you decline to accept revisions to
that information, your purchase of the notes will be canceled. |
|
● |
THE ESTIMATED VALUE OF THE NOTES WILL BE LOWER THAN THE
ORIGINAL ISSUE PRICE (PRICE TO PUBLIC) OF THE NOTES —
The estimated value of the notes is only an estimate determined by
reference to several factors. The original issue price of the notes
will exceed the estimated value of the notes because costs
associated with selling, structuring and hedging the notes are
included in the original issue price of the notes. These costs
include the selling commissions, the projected profits, if any,
that our affiliates expect to realize for assuming risks inherent
in hedging our obligations under the notes and the estimated cost
of hedging our obligations under the notes. See “The Estimated
Value of the Notes” in this pricing supplement. |
|
● |
THE ESTIMATED VALUE OF THE NOTES DOES NOT REPRESENT FUTURE
VALUES OF THE NOTES AND MAY DIFFER FROM OTHERS’ ESTIMATES —
See “The Estimated Value of the Notes” in this pricing
supplement. |
PS-5
| Structured Investments
Uncapped Accelerated Barrier Notes Linked to the Lesser Performing
of the iShares® MSCI EAFE ETF and the EURO STOXX
50® Index
|
 |
|
● |
THE ESTIMATED VALUE OF THE NOTES IS DERIVED BY REFERENCE TO
AN INTERNAL FUNDING RATE —
The internal funding rate used in the determination of the
estimated value of the notes may differ from the market-implied
funding rate for vanilla fixed income instruments of a similar
maturity issued by JPMorgan Chase & Co. or its
affiliates. Any difference may be based on, among other things, our
and our affiliates’ view of the funding value of the notes as well
as the higher issuance, operational and ongoing liability
management costs of the notes in comparison to those costs for the
conventional fixed income instruments of JPMorgan
Chase & Co. This internal funding rate is based on
certain market inputs and assumptions, which may prove to be
incorrect, and is intended to approximate the prevailing market
replacement funding rate for the notes. The use of an internal
funding rate and any potential changes to that rate may have an
adverse effect on the terms of the notes and any secondary market
prices of the notes. See “The Estimated Value of the Notes” in this
pricing supplement. |
|
● |
THE VALUE OF THE NOTES AS PUBLISHED BY JPMS (AND WHICH MAY
BE REFLECTED ON CUSTOMER ACCOUNT STATEMENTS) MAY BE HIGHER THAN THE
THEN-CURRENT ESTIMATED VALUE OF THE NOTES FOR A LIMITED TIME PERIOD
—
We generally expect that some of the costs included in the original
issue price of the notes will be partially paid back to you in
connection with any repurchases of your notes by JPMS in an amount
that will decline to zero over an initial predetermined period. See
“Secondary Market Prices of the Notes” in this pricing supplement
for additional information relating to this initial period.
Accordingly, the estimated value of your notes during this initial
period may be lower than the value of the notes as published by
JPMS (and which may be shown on your customer account
statements). |
|
● |
SECONDARY MARKET PRICES OF THE NOTES WILL LIKELY BE LOWER
THAN THE ORIGINAL ISSUE PRICE OF THE NOTES —
Any secondary market prices of the notes will likely be lower than
the original issue price of the notes because, among other things,
secondary market prices take into account our internal secondary
market funding rates for structured debt issuances and, also,
because secondary market prices may exclude selling commissions,
projected hedging profits, if any, and estimated hedging costs that
are included in the original issue price of the notes. As a result,
the price, if any, at which JPMS will be willing to buy the notes
from you in secondary market transactions, if at all, is likely to
be lower than the original issue price. Any sale by you prior to
the Maturity Date could result in a substantial loss to you. |
|
● |
SECONDARY MARKET PRICES OF THE NOTES WILL BE IMPACTED BY
MANY ECONOMIC AND MARKET FACTORS —
The secondary market price of the notes during their term will be
impacted by a number of economic and market factors, which may
either offset or magnify each other, aside from the selling
commissions, projected hedging profits, if any, estimated hedging
costs and the values of the Underlyings. Additionally, independent
pricing vendors and/or third party broker-dealers may publish a
price for the notes, which may also be reflected on customer
account statements. This price may be different (higher or lower)
than the price of the notes, if any, at which JPMS may be willing
to purchase your notes in the secondary market. See “Risk Factors —
Risks Relating to the Estimated Value and Secondary Market Prices
of the Notes — Secondary market prices of the notes will be
impacted by many economic and market factors” in the accompanying
product supplement. |
The Underlyings
The iShares® MSCI EAFE ETF is an exchange-traded fund of
iShares® Trust, a registered investment company, that
seeks to track the investment results, before fees and expenses, of
an index composed of large- and mid-capitalization developed market
equities, excluding the United States and Canada, which we refer to
as the Underlying Index with respect to the iShares®
MSCI EAFE ETF. The Underlying Index with respect to the
iShares® MSCI EAFE ETF is currently the MSCI
EAFE® Index. The MSCI EAFE® Index is a free
float-adjusted market capitalization index intended to measure the
equity market performance of certain developed markets, excluding
the United States and Canada. For additional information about the
iShares® MSCI EAFE ETF, see “Fund Descriptions — The
iShares® ETFs” in the accompanying underlying
supplement.
The EURO STOXX 50® Index consists of 50 component stocks
of market sector leaders from within the Eurozone. The EURO STOXX
50® Index and STOXX are the intellectual property
(including registered trademarks) of STOXX Limited, Zurich,
Switzerland and/or its licensors (the “Licensors”), which are used
under license. The notes based on the EURO STOXX 50®
Index are in no way sponsored, endorsed, sold or promoted by STOXX
Limited and its Licensors and neither STOXX Limited nor any of its
Licensors shall have any liability with respect thereto. For
additional information about the EURO STOXX 50® Index,
see “Equity Index Descriptions — The STOXX Benchmark Indices” in
the accompanying underlying supplement.
PS-6
| Structured Investments
Uncapped Accelerated Barrier Notes Linked to the Lesser Performing
of the iShares® MSCI EAFE ETF and the EURO STOXX
50® Index
|
 |
Historical Information
The following graphs set forth the historical performance of each
Underlying based on the weekly historical closing values from
January 5, 2018 through May 26, 2023. The closing value of the
iShares® MSCI EAFE ETF on May 31, 2023 was $70.67. The
closing value of the EURO STOXX 50® Index on May 31,
2023 was 4,218.04. We obtained the closing values above and below
from the Bloomberg Professional® service (“Bloomberg”),
without independent verification. The closing values of the Fund
above and below may have been adjusted by Bloomberg for actions
taken by the Fund, such as stock splits.
The historical closing values of each Underlying should not be
taken as an indication of future performance, and no assurance can
be given as to the closing value of either Underlying on the
Pricing Date or the Observation Date. There can be no assurance
that the performance of the Underlyings will result in the return
of any of your principal amount.
Historical Performance of the iShares® MSCI
EAFE ETF

Source: Bloomberg
|
Historical Performance of the EURO STOXX 50®
Index

Source: Bloomberg
|
PS-7
| Structured Investments
Uncapped Accelerated Barrier Notes Linked to the Lesser Performing
of the iShares® MSCI EAFE ETF and the EURO STOXX
50® Index
|
 |
Tax Treatment
You should review carefully the section entitled “Material U.S.
Federal Income Tax Consequences” in the accompanying product
supplement no. 4-I. We expect to ask our special tax counsel to
provide an opinion substantially consistent with the following
discussion at pricing.
Based on current market conditions, it is reasonable to treat the
notes as “open transactions” that are not debt instruments for U.S.
federal income tax purposes, as more fully described in “Material
U.S. Federal Income Tax Consequences—Tax Consequences to U.S.
Holders—Notes Treated as Open Transactions That Are Not Debt
Instruments” in the accompanying product supplement. Assuming this
treatment is respected, subject to the possible application of the
“constructive ownership” rules, the gain or loss on your notes
should be treated as long-term capital gain or loss if you hold
your notes for more than a year, whether or not you are an initial
purchaser of notes at the issue price. The notes could be treated
(in whole or in part) as “constructive ownership transactions”
within the meaning of Section 1260 of the Code, in which case all
or a portion of any gain recognized in respect of the notes that
would otherwise be long-term capital gain and that was in excess of
the “net underlying long-term capital gain” (as defined in Section
1260) would be treated as ordinary income, and a notional interest
charge would apply as if that income had accrued for tax purposes
at a constant yield over your holding period for the notes. We do
not expect our special tax counsel to be in a position to express
an opinion with respect to whether the constructive ownership rules
apply to the notes. Accordingly, U.S. Holders should consult their
tax advisers regarding the potential application of the
constructive ownership rules.
The IRS or a court may not respect the treatment of the notes
described above, in which case the timing and character of any
income or loss on your notes could be materially and adversely
affected. In addition, in 2007 Treasury and the IRS released a
notice requesting comments on the U.S. federal income tax treatment
of “prepaid forward contracts” and similar instruments. The notice
focuses in particular on whether to require investors in these
instruments to accrue income over the term of their investment. It
also asks for comments on a number of related topics, including the
character of income or loss with respect to these instruments; the
relevance of factors such as the nature of the underlying property
to which the instruments are linked; the degree, if any, to which
income (including any mandated accruals) realized by non-U.S.
investors should be subject to withholding tax; and whether these
instruments are or should be subject to the constructive ownership
regime described above. While the notice requests comments on
appropriate transition rules and effective dates, any Treasury
regulations or other guidance promulgated after consideration of
these issues could materially and adversely affect the tax
consequences of an investment in the notes, possibly with
retroactive effect. You should consult your tax adviser regarding
the U.S. federal income tax consequences of an investment in the
notes, including the potential application of the constructive
ownership rules, possible alternative treatments and the issues
presented by this notice.
Section 871(m) of the Code and Treasury regulations promulgated
thereunder (“Section 871(m)”) generally impose a 30% withholding
tax (unless an income tax treaty applies) on dividend equivalents
paid or deemed paid to Non-U.S. Holders with respect to certain
financial instruments linked to U.S. equities or indices that
include U.S. equities. Section 871(m) provides certain exceptions
to this withholding regime, including for instruments linked to
certain broad-based indices that meet requirements set forth in the
applicable Treasury regulations. Additionally, a recent IRS notice
excludes from the scope of Section 871(m) instruments issued prior
to January 1, 2025 that do not have a delta of one with respect to
underlying securities that could pay U.S.-source dividends for U.S.
federal income tax purposes (each an “Underlying Security”). Based
on certain determinations made by us, we expect that Section 871(m)
will not apply to the notes with regard to Non-U.S. Holders. Our
determination is not binding on the IRS, and the IRS may disagree
with this determination. Section 871(m) is complex and its
application may depend on your particular circumstances, including
whether you enter into other transactions with respect to an
Underlying Security. If necessary, further information regarding
the potential application of Section 871(m) will be provided in the
pricing supplement for the notes. You should consult your tax
adviser regarding the potential application of Section 871(m) to
the notes.
The Estimated Value of the Notes
The estimated value of the notes set forth on the cover of this
pricing supplement is equal to the sum of the values of the
following hypothetical components: (1) a fixed-income debt
component with the same maturity as the notes, valued using the
internal funding rate described below, and (2) the derivative or
derivatives underlying the economic terms of the notes. The
estimated value of the notes does not represent a minimum price at
which JPMS would be willing to buy your notes in any secondary
market (if any exists) at any time. The internal funding rate used
in the determination of the estimated value of the notes may differ
from the market-implied funding rate for vanilla fixed income
instruments of a similar maturity issued by JPMorgan
Chase & Co. or its affiliates. Any difference may be
based on, among other things, our and our affiliates’ view of the
funding value of the notes as well as the higher issuance,
operational and ongoing liability management costs of the notes in
comparison to those costs for the conventional fixed income
instruments of JPMorgan Chase & Co. This internal
funding rate is based on certain market inputs and assumptions,
which may prove to be incorrect, and is intended to approximate the
prevailing market replacement funding rate for the notes. The use
of an internal funding rate and any potential changes to that rate
may have an adverse effect on the terms of the notes and any
secondary market prices of the notes. For additional information,
see “Selected Risk Considerations — The Estimated Value of the
Notes Is Derived by Reference to an Internal Funding Rate” in this
pricing supplement.
PS-8
| Structured Investments
Uncapped Accelerated Barrier Notes Linked to the Lesser Performing
of the iShares® MSCI EAFE ETF and the EURO STOXX
50® Index
|
 |
The value of the derivative or derivatives underlying the economic
terms of the notes is derived from internal pricing models of our
affiliates. These models are dependent on inputs such as the traded
market prices of comparable derivative instruments and on various
other inputs, some of which are market-observable, and which can
include volatility, dividend rates, interest rates and other
factors, as well as assumptions about future market events and/or
environments. Accordingly, the estimated value of the notes is
determined when the terms of the notes are set based on market
conditions and other relevant factors and assumptions existing at
that time.
The estimated value of the notes does not represent future values
of the notes and may differ from others’ estimates. Different
pricing models and assumptions could provide valuations for the
notes that are greater than or less than the estimated value of the
notes. In addition, market conditions and other relevant factors in
the future may change, and any assumptions may prove to be
incorrect. On future dates, the value of the notes could change
significantly based on, among other things, changes in market
conditions, our or JPMorgan Chase & Co.’s
creditworthiness, interest rate movements and other relevant
factors, which may impact the price, if any, at which JPMS would be
willing to buy notes from you in secondary market transactions.
The estimated value of the notes will be lower than the original
issue price of the notes because costs associated with selling,
structuring and hedging the notes are included in the original
issue price of the notes. These costs include the selling
commissions paid to JPMS and other affiliated or unaffiliated
dealers, the projected profits, if any, that our affiliates expect
to realize for assuming risks inherent in hedging our obligations
under the notes and the estimated cost of hedging our obligations
under the notes. Because hedging our obligations entails risk and
may be influenced by market forces beyond our control, this hedging
may result in a profit that is more or less than expected, or it
may result in a loss. A portion of the profits, if any, realized in
hedging our obligations under the notes may be allowed to other
affiliated or unaffiliated dealers, and we or one or more of our
affiliates will retain any remaining hedging profits. See “Selected
Risk Considerations — The Estimated Value of the Notes Will Be
Lower Than the Original Issue Price (Price to Public) of the Notes”
in this pricing supplement.
Secondary Market Prices of the Notes
For information about factors that will impact any secondary market
prices of the notes, see “Risk Factors — Risks Relating to the
Estimated Value and Secondary Market Prices of the Notes —
Secondary market prices of the notes will be impacted by many
economic and market factors” in the accompanying product
supplement. In addition, we generally expect that some of the costs
included in the original issue price of the notes will be partially
paid back to you in connection with any repurchases of your notes
by JPMS in an amount that will decline to zero over an initial
predetermined period. These costs can include selling commissions,
projected hedging profits, if any, and, in some circumstances,
estimated hedging costs and our internal secondary market funding
rates for structured debt issuances. This initial predetermined
time period is intended to be the shorter of six months and
one-half of the stated term of the notes. The length of any such
initial period reflects the structure of the notes, whether our
affiliates expect to earn a profit in connection with our hedging
activities, the estimated costs of hedging the notes and when these
costs are incurred, as determined by our affiliates. See “Selected
Risk Considerations — The Value of the Notes as Published by JPMS
(and Which May Be Reflected on Customer Account Statements) May Be
Higher Than the Then-Current Estimated Value of the Notes for a
Limited Time Period” in this pricing supplement.
Supplemental Use of Proceeds
The notes are offered to meet investor demand for products that
reflect the risk-return profile and market exposure provided by the
notes. See “Hypothetical Payout Profile” and “How the Notes Work”
in this pricing supplement for an illustration of the risk-return
profile of the notes and “The Underlyings” in this pricing
supplement for a description of the market exposure provided by the
notes.
The original issue price of the notes is equal to the estimated
value of the notes plus the selling commissions paid to JPMS and
other affiliated or unaffiliated dealers, plus (minus) the
projected profits (losses) that our affiliates expect to realize
for assuming risks inherent in hedging our obligations under the
notes, plus the estimated cost of hedging our obligations under the
notes.
Additional Terms Specific to the Notes
You may revoke your offer to purchase the notes at any time prior
to the time at which we accept such offer by notifying the
applicable agent. We reserve the right to change the terms of, or
reject any offer to purchase, the notes prior to their issuance. In
the event of any changes to the terms of the notes, we will notify
you and you will be asked to accept such changes in connection with
your purchase. You may also choose to reject such changes, in which
case we may reject your offer to purchase.
You should read this pricing supplement together with the
accompanying prospectus, as supplemented by the accompanying
prospectus supplement relating to our Series A medium-term notes of
which these notes are a part, and the more detailed information
contained in the accompanying product supplement and the
accompanying underlying supplement. This pricing supplement,
together with the documents listed below, contains the terms of the
notes and supersedes all other prior or contemporaneous oral
statements as well as any other written materials including
preliminary or indicative pricing terms, correspondence, trade
ideas, structures for implementation, sample structures, fact
sheets, brochures or other educational materials of ours. You
should carefully consider, among other things, the matters set
forth in the “Risk Factors” sections of the accompanying prospectus
supplement and the accompanying product supplement, as the notes
involve risks not associated with conventional debt securities. We
urge you to consult your investment, legal, tax, accounting and
other advisers before you invest in the notes.
PS-9
| Structured Investments
Uncapped Accelerated Barrier Notes Linked to the Lesser Performing
of the iShares® MSCI EAFE ETF and the EURO STOXX
50® Index
|
 |
You may access these documents on the SEC website at www.sec.gov
as follows (or if such address has changed, by reviewing our
filings for the relevant date on the SEC website):
Our Central Index Key, or CIK, on the SEC website is 1665650, and
JPMorgan Chase & Co.’s CIK is 19617. As used in this
pricing supplement, “we,” “us” and “our” refer to JPMorgan
Financial.
PS-10
| Structured Investments
Uncapped Accelerated Barrier Notes Linked to the Lesser Performing
of the iShares® MSCI EAFE ETF and the EURO STOXX
50® Index
|
 |
JP Morgan Chase (NYSE:JPM)
Historical Stock Chart
Von Aug 2023 bis Sep 2023
JP Morgan Chase (NYSE:JPM)
Historical Stock Chart
Von Sep 2022 bis Sep 2023